Jump to content
RemedySpot.com

Tobacco Worker's Lung

Rate this topic


Guest guest

Recommended Posts

Be sure to read the NOTE at the bottom.

Tobacco Worker's Lung

Last Updated: January 21, 2003 Rate this Article

Email to a Colleague

http://www.emedicine.com/med/topic2282.htm

Synonyms and related keywords: hypersensitivity pneumonitis, HP,

extrinsic allergic pneumonitis, EAA, TWL, parenchymal lung diseases,

tobacco molds

AUTHOR INFORMATION Section 1 of 10

Author Information Introduction Clinical Differentials Workup

Treatment Medication Follow-up Miscellaneous Bibliography

Author: Olade, MD, MPH, Fellow, Occupational And Environmental

Medicine, Harvard School Of Public Health, Massachusetts General

Hospital

Coauthor(s): Klaus-Dieter Lessnau, MD, FCCP, Clinical Assistant

Professor of Medicine, New York University School of Medicine;

Medical Director, Pulmonary Physiology Laboratory, Department of

Medicine, Section of Pulmonary Medicine, Lenox Hill Hospital

Olade, MD, MPH, is a member of the following medical

societies: American College of Occupational and Environmental

Medicine, and American College of Physicians

Editor(s): Sat Sharma, MD, FRCPC, FACP, FCCP, DABSM, Program

Director, Associate Professor, Department of Internal Medicine,

Divisions of Pulmonary and Critical Care Medicine, University of

Manitoba; Site Coordinator of Respiratory Medicine, St Boniface

General Hospital; Francisco Talavera, PharmD, PhD, Senior Pharmacy

Editor, eMedicine; Gregg T Anders, DO, Medical Director, Great

Plains Regional Medical Command, Brook Army Medical Center; Clinical

Associate Professor, Department of Internal Medicine, Division of

Pulmonary Disease, University of Texas Health Science Center at San

; D Rice, MD, Associate Professor, Departments of

Internal Medicine and Pediatrics and Adolescent Medicine, Saint

Louis University School of Medicine; and Zab Mohsenifar, MD,

Director, Division of Pulmonary/Critical Care Medicine, Department

of Medicine, Cedars-Sinai Medical Center; Professor, Department of

Internal Medicine, University of California at Los Angeles School of

Medicine

Disclosure INTRODUCTION Section 2 of 10

Author Information Introduction Clinical Differentials Workup

Treatment Medication Follow-up Miscellaneous Bibliography

Background: Tobacco worker's lung (TWL) is one disease in the group

of parenchymal lung diseases categorized as hypersensitivity

pneumonitis (United States) or extrinsic allergic alveolitis

(Britain). This disease entity is caused by inhalation of tobacco

molds and is encountered in persons who work in tobacco fields and

cigarette manufacturing plants.

Increased humidity plays a major role in favoring mold growth. The

clinical features and natural history are akin to hypersensitivity

pneumonitis of other causes.

Pathophysiology: Immune mediation plays a major pathogenetic role in

TWL. Serum antibodies are present in most patients with TWL, but a

lack of correlation between the presence of serum antibodies and

pulmonary symptoms has been noted.

In TWL, the culprit antigen is the Aspergillus species, with a

source in tobacco molds. The antigens induce injury by causing

macrophages and polymorphonuclear leukocytes to produce substances

such as proteolytic enzymes and reactive oxygen compounds. These

further lead to synthesis and release of interleukin (IL)-1, tumor

necrosis factor (TNF)-alpha, and IL-6 from macrophages and

lymphokines from lymphocytes, which result in pulmonary

inflammation. Lung biopsies in patients with long-term exposure

usually demonstrate chronic interstitial inflammation and poorly

formed nonnecrotizing granulomas.

Frequency:

In the US: Data are not available.

Internationally: Data are not available.

Mortality/Morbidity: Because of the excellent prognosis, little

documented evidence of long-term illness or death from TWL exists.

Sex: Although no documented evidence indicates a sex predilection,

TWL is more common in males, probably because most tobacco workers

are men.

Age: TWL occurs in adults of working age but not in children or

retired people. CLINICAL Section 3 of 10

Author Information Introduction Clinical Differentials Workup

Treatment Medication Follow-up Miscellaneous Bibliography

History:

A comprehensive history of exposure to tobacco mold and leaves

should be obtained.

TWL, as with most hypersensitivity pneumonitis syndromes, has acute,

subacute, and chronic presentations.

In acute presentations, patients develop abrupt onset of fever,

cough, chills, myalgias, headache, and malaise about 4-6 hours

following exposure to tobacco plants and molds. These symptoms are

self-limited, resolving in 12 hours to several days once the patient

avoids the inciting agent. The symptoms may recur with reexposure.

Patients who have had long-term exposure to tobacco plantations

usually have insidious onset of cough, exertional dyspnea, fatigue,

and weight loss. Disabling and irreversible respiratory findings due

to pulmonary fibrosis may occur late in the course of the disease.

Removing patients from tobacco exposure results in only partial

improvement.

Physical: Physical examination reveals the following:

Tachypnea

Diffuse fine rales

Wheezing

Weight loss

Digital clubbing

Fever

Evidence of cor pulmonale

Causes: Major causative antigens include the following:

Aspergillus species

Scopulariopsis brevicaulis

DIFFERENTIALS Section 4 of 10

Author Information Introduction Clinical Differentials Workup

Treatment Medication Follow-up Miscellaneous Bibliography

Chronic Bronchitis

Pulmonary Fibrosis, Idiopathic

Sarcoidosis

Other Problems to be Considered:

Inhalation fever (Monday illness)

Organic-dust toxic syndrome

Allergic bronchopulmonary aspergillosis

Pneumoconiosis

Bagassosis

Byssinosis

Quick Find

Author Information

Introduction

Clinical

Differentials

Workup

Treatment

Medication

Follow-up

Miscellaneous

Bibliography

Click for related images.

Related Articles

Chronic Bronchitis

Pulmonary Fibrosis, Idiopathic

Sarcoidosis

Continuing Education

CME available for this topic. Click here to take this CME.

Patient Education

Click here for patient education.

WORKUP Section 5 of 10

Author Information Introduction Clinical Differentials Workup

Treatment Medication Follow-up Miscellaneous Bibliography

Lab Studies:

No specific tests exist for TWL; the diagnosis is established with a

history of exposure and possibly with the support of the following

tests.

Elevated serum levels of angiotensin-converting enzyme (ACE), N-

acetyl-beta-glucosaminidase (NAG), and beta-glucuronidase (beta-GLU)

may be present. Elevation of these enzymes does not have a high

sensitivity or specificity.

Bronchoalveolar lavage (BAL) may show lymphocytosis, neutrophilia or

eosinophilia, and reversal of CD4/CD8 ratio.

Immunoglobulin (Ig)G, IgM, and IgA serum antibodies to causative

antigens may be present.

Nonspecific markers of inflammation are elevated.

Elevated erythrocyte sedimentation rate

Elevated C-reactive protein

Positive rheumatoid factor

Elevated serum lactate dehydrogenase (LDH)

Imaging Studies:

Chest radiograph: No distinctive changes are noted on chest

radiography, but it might show progressive fibrotic changes

associated with upper lobe volume loss or diffuse reticulonodular

infiltrates in chronic exposure. In acute exposure, the infiltrates

are usually more prevalent in the lower lobes.

High-resolution computed tomography (HRCT) scan: This may show a

ground-glass appearance, prominent medium-sized bronchial walls,

parenchymal micronodules, and absence of hilar adenopathy.

Other Tests:

Pulmonary function testing shows mostly restrictive patterns with

occasionally mixed restrictive and obstructive patterns, impaired

diffusion capacity, and lung volume loss.

Arterial hypoxemia with hypocapnia reflecting an increased A-a

oxygen gradient commonly occurs at rest, with further worsening on

exercise.

Procedures:

Lung biopsies are rarely required to confirm diagnosis because

diagnosis is primarily derived from a thorough occupational history,

clinical features, and radiography. Both transbronchial and video-

assisted thoracoscopic lung biopsy are used to provide adequate

specimens for histopathological examination.

Histologic Findings: Samples from lung biopsies show chronic

interstitial inflammation with infiltration of plasma cells, mast

cells, macrophages, and lymphocytes, usually with poorly formed

nonnecrotizing granulomas. The granulomas are loosely formed and

tend to occur in proximity to the bronchioles. Cholesterol clefts

and giant cells also are observed within and outside the granulomas.

TREATMENT Section 6 of 10

Author Information Introduction Clinical Differentials Workup

Treatment Medication Follow-up Miscellaneous Bibliography

Medical Care:

No medical treatment is available for TWL.

The major treatment strategy is elimination of exposure to tobacco

molds or leaves.

Systemic glucocorticoids have been used to treat patients with TWL

but without any good evidence of effectiveness, especially in

patients with chronic exposure.

Removal from exposure to the offending agents usually leads to

symptom resolution.

Consultations: Pulmonology

MEDICATION Section 7 of 10

Author Information Introduction Clinical Differentials Workup

Treatment Medication Follow-up Miscellaneous Bibliography

No medications are available.

FOLLOW-UP Section 8 of 10

Author Information Introduction Clinical Differentials Workup

Treatment Medication Follow-up Miscellaneous Bibliography

Further Outpatient Care:

Patients should receive supportive follow-up care at a chest clinic.

Deterrence/Prevention:

Avoidance of exposure to tobacco leaves is the best prevention.

Complications:

Some patients have irreversible lung damage progressing to pulmonary

fibrosis with resultant cor pulmonale.

Prognosis:

The prognosis is excellent if exposure to tobacco plants is

curtailed before permanent damage occurs.

Patient Education:

Inform tobacco workers about the possible risk of chronic lung

damage from continuous exposure and that they should seek medical

attention if certain symptoms are noted.

MISCELLANEOUS Section 9 of 10

Author Information Introduction Clinical Differentials Workup

Treatment Medication Follow-up Miscellaneous Bibliography

Medical/Legal Pitfalls:

Medicolegal issues could ensue if the physician fails to recognize

the relationship between occupational exposure and symptoms.

Workers' compensation usually covers treatment if the exposure was

at work.

BIBLIOGRAPHY Section 10 of 10

Author Information Introduction Clinical Differentials Workup

Treatment Medication Follow-up Miscellaneous Bibliography

Bhisey RA, Bagwe AN, Mahimkar MB: Biological monitoring of bidi

industry workers occupationally exposed to tobacco. Toxicol Lett

1999; 108: 259-65[Medline].

Ghosh SK, Parikh JR, Gokani VN: Studies on occupational health

problems during agricultural operation of Indian workers: a

preliminary survey report. J Occup Med 1: 45-7[Medline].

Huuskonen MS, Husman K, Jarvisalo J: Extrinsic allergic alveolitis

in the tobacco industry. Br J Ind Med 1984; 1: 77-83[Medline].

Huuskonen MS, Jarvisalo J, Koskinen H: Serum angiotensin-converting

enzyme and lysosomal enzymes in tobacco workers. Chest 1986; 2: 224-8

[Medline].

Kusemamariwo T, Neill P: Carcinoma of the bronchus in tobacco farm

workers. An unrecognised high risk group. Trop Geogr Med 1990; 3:

261-4[Medline].

NOTE:

Medicine is a constantly changing science and not all therapies are

clearly established. New research changes drug and treatment

therapies daily. The authors, editors, and publisher of this journal

have used their best efforts to provide information that is up-to-

date and accurate and is generally accepted within medical standards

at the time of publication. However, as medical science is

constantly changing and human error is always possible, the authors,

editors, and publisher or any other party involved with the

publication of this article do not warrant the information in this

article is accurate or complete, nor are they responsible for

omissions or errors in the article or for the results of using this

information. The reader should confirm the information in this

article from other sources prior to use. In particular, all drug

doses, indications, and contraindications should be confirmed in the

package insert. FULL DISCLAIMER

Tobacco Worker's Lung excerpt

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...